Table 3 PD-L1 expression in stage 0–IA lung adenocarcinoma with driven genes (p: vs Driven gene negative)
From: Expression of PD-L1 through evolution phase from pre-invasive to invasive lung adenocarcinoma
PDL1 (−) (%) | PD-L1 ≥ 1% | p value | PD-L1 ≥ 50% | p value | Total | ||||
|---|---|---|---|---|---|---|---|---|---|
EGFR ( +) | 609 | 91.72 | 56 | 8.43 | 0.795 | 5 | 0.75 | 0.353 | 665 |
ALK ( +) | 20 | 80.00 | 5 | 20.00 | 0.068 | 2 | 8.00 | 0.046 | 25 |
ROS-1 ( +) | 5 | 55.56 | 4 | 44.44 | 0.006 | 1 | 11.11 | N/A | 9 |
Kras ( +) | 17 | 68.00 | 8 | 32.00 | 0.001 | 1 | 4.00 | N/A | 25 |
RET ( +) | 10 | 90.91 | 1 | 9.09 | N/A | 0 | 0.00 | N/A | 11 |
HER2 ( +) | 23 | 100.00 | 0 | 0.00 | N/A | 0 | 0.00 | N/A | 23 |
BRAF ( +) | 3 | 100.00 | 0 | 0.00 | N/A | 0 | 0.00 | N/A | 3 |
Driven gene (−) | 337 | 92.84 | 26 | 7.16 | 6 | 1.65 | 363 | ||
Total | 1024 | 91.18 | 99 | 8.82 | 15 | 1.34% | 1123 | ||